TNF and myelodysplastic syndrome: TIGIT can directly inhibit the antitumor immune function mediated by NK and T cells and indirectly reduce the secretion of activated cytokines such as CD107a, IFN-γ and TNF-α to participate in disease progression and immune escape of MDS (55).